An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...
An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback